1. Home
  2. NEWS
  3. Viron's CEO unveils Viron C1, an anti-COVID-19 nasal spray

Viron's CEO unveils Viron C1, an anti-COVID-19 nasal spray

Viron's CEO unveils Viron C1, an anti-COVID-19 nasal spray

December 17, 2021

Porosome Therapeutics Unveils Groundbreaking Discovery in Alzheimer’s Disease Research and Treatment
Porosome Therapeutics, Inc. CEO and Chairman are Interviewed in Cambridge, MA
FDA Grants Orphan Drug Designation to Revolutionary Cystic Fibrosis Therapy